Treatment strategies for lysosomal storage disorders

Developmental Medicine and Child Neurology
Michael Beck

Abstract

Over the past several years the number of treatments available for patients with lysosomal storage disorders has rapidly increased. Haematopoietic stem cell transplantation, enzyme replacement therapy, substrate reduction, and chaperone therapies are currently available, and gene therapies and other treatments are rapidly advancing. Despite remarkable advances, the efficacy of most of these therapies is limited, particularly because the treatments are usually initiated when organ damage has already occurred. To circumvent this limitation, screening in newborn infants for lysosomal storage disorders has been introduced in many countries. However, this screening is complicated by the broad clinical variability of the disorders and the fact that many individuals who will be detected as having an enzyme deficiency will develop symptoms very late or never in their life. This paper provides an overview of available therapies for lysosomal storage disorders and describes those treatments that are under development. For a few lysosomal storage disorders, new therapies are available or under development. These therapies include enzyme replacement therapy, small molecules, and gene therapy. The new therapies cannot cure patients, but can...Continue Reading

References

Mar 21, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mark S Sands, Beverly L Davidson
Jun 27, 2006·Trends in Molecular Medicine·Doug A BrooksJohn J Hopwood
Jan 2, 2009·Pediatrics·Joseph MuenzerUNKNOWN International Consensus Panel on Management and Treatment of Mucopolysaccharidosis I
Nov 11, 2009·Pediatrics·Joseph MuenzerE Wraith
Jun 4, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Suhrad G BanugariaPriya S Kishnani
Jan 26, 2012·Annals of Neurology·Jessica de RuijterFrits A Wijburg
May 11, 2012·Molecular Genetics and Metabolism·Marc C PattersonUNKNOWN NP-C Guidelines Working Group
Jan 15, 2014·Molecular Genetics and Metabolism·Gwen GunnKim M Keeling
Aug 12, 2014·Annals of Neurology·Michele D PoeMaria L Escolar
Dec 6, 2014·Clinical Chemistry·Michael H GelbFrantisek Turecek
Jan 13, 2015·Molecular Genetics and Metabolism·Keith Van HarenUNKNOWN GLIA Consortium
May 24, 2016·Molecular Genetics and Metabolism·Simon A JonesFrits A Wijburg
Jun 9, 2016·Human Gene Therapy·Michaël HocquemillerNathalie Cartier
Sep 4, 2016·Journal of Inherited Metabolic Disease·Julia B HennermannCalogera M Simonaro
Sep 9, 2016·Science Translational Medicine·Thomas KirkegaardFrances M Platt
Feb 6, 2017·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Juan Eduardo Megías-VericatJosé Luis Poveda
Feb 10, 2017·Journal of Pediatric Genetics·Roy W A Peake, Olaf A Bodamer
Feb 28, 2017·BMC Medicine·Jessica L SchnellerCharles P Venditti
Mar 28, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Priya KishnaniBarry Byrne
May 31, 2017·Nature Methods·Kellie A SchaeferVinit B Mahajan

❮ Previous
Next ❯

Citations

Sep 4, 2019·Nature Reviews. Drug Discovery·Srinivasa Reddy BonamSylviane Muller
Dec 7, 2019·Traffic·Mariana E G de AraujoLukas A Huber
Jul 30, 2020·Biomolecules·Filippo Pinto E VairoRoberto Giugliani
Jan 17, 2020·International Journal of Molecular Sciences·Edina PolettoNatalia Gomez-Ospina
Dec 15, 2019·Nature Reviews. Drug Discovery·Erik TambuyzerMarco Prunotto
May 22, 2020·Frontiers in Molecular Biosciences·T Zhang, R T Peterson
Jun 5, 2020·Acta Crystallographica. Section D, Structural Biology·Rhianna J RowlandGideon J Davies
Dec 14, 2018·Frontiers in Physiology·Valeriya V SolovyevaAlbert A Rizvanov
Jan 16, 2020·International Journal of Molecular Sciences·Yuji Sato, Torayuki Okuyama
Jan 18, 2019·Journal of Cell Science·André R A Marques, Paul Saftig
May 9, 2019·Genetics and Molecular Biology·Fabiano de Oliveira PoswarRoberto Giugliani
Feb 6, 2020·International Journal of Molecular Sciences·Congwu ChiKunhua Song
Aug 23, 2020·Cells·Valentina La CognataSebastiano Cavallaro
Sep 10, 2020·Frontiers in Cell and Developmental Biology·Sudan PuriVivien J Coulson-Thomas
Oct 30, 2020·The Biochemical Journal·Torben Lübke, Markus Damme
Aug 3, 2019·European Journal of Medicinal Chemistry·Lucia BiasuttoMario Zoratti
May 5, 2021·Lipids in Health and Disease·Muna Abed RabboJohnny Stiban
Aug 7, 2021·Neuroscience Letters·Steven U Walkley
Nov 2, 2021·Frontiers in Immunology·Ariel S WirchnianskiKartik Chandran

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
S BruniG V Coppa
Molecular Genetics and Metabolism
Ellen SidranskyEdward I Ginns
Journal of Inherited Metabolic Disease
Carla E M Hollak, Frits A Wijburg
Recent Patents on CNS Drug Discovery
Lorena UrbanelliCarla Emiliani
Annual Review of Medicine
Giancarlo ParentiAndrea Ballabio
© 2022 Meta ULC. All rights reserved